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Abstract
IMPORTANCE Although previous work has examined clinical outcomes in combat-deployed
veterans, questions remain regarding how symptoms evolve or resolve followingmild blast traumatic
brain injury (TBI) treated in theater and their association with long-term outcomes.
OBJECTIVE To characterize 5-year outcome in patients with nonmedically evacuated blast
concussion compared with combat-deployed controls and understand what clinical measures
collected acutely in theater are associated with 5-year outcome.
DESIGN, SETTING, AND PARTICIPANTS A prospective, longitudinal cohort study including 45
service members with mild blast TBI within 7 days of injury (mean 4 days) and 45 combat deployed
nonconcussed controls was carried out. Enrollment occurred in Afghanistan at the point of injury
with evaluation of 5-year outcome in the United States. The enrollment occurred fromMarch to
September 2012 with 5-year follow up completed from April 2017 to May 2018. Data analysis was
completed from June to July 2018.
EXPOSURES Concussive blast TBI. All patients were treated in theater, and none requiredmedical
evacuation.
MAINOUTCOMES ANDMEASURES Clinical measures collected in theater includedmeasures for
concussion symptoms, posttraumatic stress disorder (PTSD) symptoms, depression symptoms,
balance performance, combat exposure intensity, cognitive performance, and demographics. Five-
year outcome evaluation includedmeasures for global disability, neurobehavioral impairment, PTSD
symptoms, depression symptoms, and 10 domains of cognitive function. Forward selection
multivariate regression was used to determine predictors of 5-year outcome for global disability,
neurobehavior impairment, PTSD, and cognitive function.
RESULTS Nonmedically evacuated patients with concussive blast injury (n = 45; 44men, mean [SD]
age, 31 [5] years) fared poorly at 5-year follow-up comparedwith combat-deployed controls (n = 45;
35men; mean [SD] age, 34 [7] years) on global disability, neurobehavioral impairment, and
psychiatric symptoms, whereas cognitive changes were unremarkable. Acute predictors of 5-year
outcome consistently identified TBI diagnosis with contribution from acute concussion andmental
health symptoms and select measures of cognitive performance depending on the model for 5-year
global disability (area under the curve following bootstrap validation [AUCBV] = 0.79),
neurobehavioral impairment (correlation following bootstrap validation [RBV] = 0.60), PTSD severity
(RBV = 0.36), or cognitive performance (RBV = 0.34).
(continued)
Key Points
Question What clinical measures
collected acutely in combat are
associated with 5-year outcome in
patients with concussive blast injury?
Findings In this longitudinal cohort
study, nonmedically evacuated blast
concussion patients had significant and
sustained symptoms of neurobehavioral
impairment, mental health and global
disability, whereas cognitive changes
were unremarkable compared with
combat-deployed nonconcussed
controls. Assessments collected in
theater were associated with multiple
domains of outcome.
Meaning Nonmedically evacuated
patients with concussive blast injury,
considered themildest of themild
combat casualties fared poorly 5 years
later compared with combat-deployed
controls.
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Abstract (continued)
CONCLUSIONS AND RELEVANCE Service members with concussive blast injuries fared poorly at
5-year outcome. The results support a more focused acute screening of mental health following TBI
diagnosis as strong indicators of poor long-term outcome. This extends prior work examining
outcome in patients with concussive blast injury to the larger nonmedically evacuated population.
JAMA Network Open. 2019;2(1):e186676. doi:10.1001/jamanetworkopen.2018.6676
Introduction
The long-term clinical impact of war-timemild blast-related traumatic brain injury (TBI) remains
incompletely described.1,2 Previous studies have been based largely on self-report and screening
tools3-6 to define TBI, rather than direct clinical assessments in cohorts identified at the time of injury
and prospectively studied. Althoughmuch effort has been expended to better understand this type
of concussive TBI, many studies in active-duty USmilitary and veterans have been restricted to cross-
sectional evaluations,4,7-15 often involving retrospective record review7-9,16 or
self-report,4,6,10-12,14,16-19 and considering only chronic phases of injury.13,16,18,20,21
Few longitudinal studies have been completed in this population, largely restricted to the first
year after exposure19,22-26 or by serial evaluation only in the chronic stage.27,28 One prior study
compared predeployment, postdeployment, andmore than 5-year follow-up; however, the study did
not restrict inclusion to just mild TBI and did not discriminate betweenmedically evacuated vs
nonmedically evacuated cases.29 The findings and prior body of literature motivate further research
to better characterize risk factors that can be associated with long-term outcomes after specifically
mild TBI exposures in combat. Questions remain regarding how symptoms evolve or resolve
followingmild blast-related TBI treated in theater and how they are associated with the service
member’s long-term trajectory.
Our ownwork has shown an evolution, not resolution, of symptoms by 5-year follow-up in
patients with blast-relatedmild TBI30,31 who weremedically evacuated from the combat theater.
Less is known about the long-term outcome trajectory in the larger population of nonmedically
evacuated service members who sustain blast-relatedmild TBI, mild enough to remain in theater for
treatment and return to their unit. Through collaborative efforts at Kandahar Airfield, Camp
Leatherneck, and academic universities in the United States, we have been provided the unique
opportunity to follow the very same patients from the point of injury in theater32 to both 1-year,22
and now 5-year outcome. The objective of the current study was to characterize 5-year outcome in
patients with nonmedically evacuated mild blast TBI and to understand what clinical measures
collected within the first week of injury in combat best predicted clinical outcome 5 years later
because this has important implications for acute care considerations of combat casualties who have
sustained these concussion exposures.
Methods
Participants were initially enrolled at Kandahar Air Field and Camp Leatherneck in Afghanistan
betweenMarch and September 2012 through a prospective, observational, research study.22,32 As
part of ongoing efforts, these very same participants have been followed to 1-year,22 and now to
5-year follow-up (completed April 2017 to May 2018). In all, 212 participants were originally enrolled
in combat (106 controls, 106 concussive blast).32 Owing to funding limitations, only 100were invited
for 5-year follow-up as was done for 1-year follow-up,22 and priority was placed on bringing back
those who had completed prior follow-up evaluation. Two groups were enrolled, blast-related
combat concussion and combat-deployed controls. Inclusion criteria for the concussion group were
(1) clinical diagnosis of mild uncomplicated or concussive TBI from a blast exposure within the past 7
days made by a trained, board-certified neurologist or neurosurgeon based on the criteria from the
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American Congress of Rehabilitation Medicine 1993 (loss of consciousness 0-30minutes,
posttraumatic amnesia <24 hours, Glasgow coma scale 13-15, absent radiological findings), (2) injury
from blast exposure within 7 days of enrollment, (3) US military, (4) ability to provide informed
consent in person, (5) no contraindications to magnetic resonance imaging (MRI) such as retained
metallic fragments, (6) no prior history of moderate to severe TBI based on Department of Defense
criteria, (7) no prior history of mental health or psychiatric diagnosis, (8) and agreement to
communicate by telephone or email and then travel to University of Washington for in-person
follow-up. Inclusion criteria for the combat-deployed control group were the same except for a
negative assessment for TBI and no history of blast exposure. The research protocol was approved
by the institutional review board at the University of Washington and the US ArmyMedical Research
andMaterial Command institutional review board. This studywas conducted in accordancewith the
approved protocol. Written informed consent was obtained from all participants in person at each
time point; no surrogate consent was allowed. See eMethods in the Supplement for further details.
For the concussion group, no intracranial abnormalities were detected on noncontrast head
computed tomographic (CT) results at the time of enrollment.32 All concussion patients met the
Department of Defense criteria for uncomplicated, mild TBI. All clinical histories were verified by
study personnel taking additional clinical history and reviewingmedical records. Mean (SD) time
from injury to enrollment was 3.76 (1.74) days with a total range of 0 to 7 days. At the 5-year
follow-up, further history was taken to assess whether there had been any additional injuries or
exposures between the time of enrollment and the follow-up evaluation years later that could affect
long-term outcome. Race/ethnicity was collected as a demographic variable and was identified by
the participant at follow-up.
Acute Evaluation Assessments
At the time of enrollment in Afghanistan, the following assessments were completed by both
concussion and combat-deployed control participants: Rivermead Post-Concussion Symptom
Questionnaire (RPCSQ),33 Posttraumatic Stress Disorder Check List-Military (PCL-M),34 Beck
Depression Inventory (BDI),35 Combat Exposure Scale,36 Balance Error Scoring System (BESS),37
Automated Neurocognitive Assessment Metrics–Traumatic Brain Injury Military Version 4 (ANAM),38
and Test ofMemoryMalingering.39 Total examination time took approximately 1 hour and 15minutes.
5-Year Follow-up Evaluation Assessments
In-person clinical evaluations at University of Washington included a structured neurobehavioral
interview, neuropsychological battery consisting of 10 cognitive tests, and structured psychiatric
evaluation with additional self-administered questionnaires. Evaluations lasted approximately 5
hours: 1 hour of standardized neurological assessment, 2 hours for cognitive testing, and 2 hours for
psychiatric evaluation. Participants took all medications as prescribed by their clinicians. All tests
were performed between 8 AM and 5 PM in private, quiet, well-lighted rooms. All examiners were
blinded to prior diagnoses and clinical histories, although during some of the interviews it may have
become clear which group participants were in given endorsements of prior events. All examiners
were psychometrists who underwent standardized training for administration.
Overall global disability was assessed using the GlasgowOutcome Scale Extended (GOS-E).40,41
Participants were instructed to consider deployment as the reference point for this interview. Poor
outcome was defined as GOS-E 6 or less indicating moderate to severe disability. Additional
information on the GOS-E and further neuropsychological battery details can be found in the
Supplement.
The neurological assessment included a structured interview designed for patients with TBI
(Neurobehavioral Rating Scale-Revised [NRS-R]42) scored with the 5 subdomains,43 2 headache
interviews capturing frequency and intensity (Migraine Disability Assessment44 and Headache
Impact Test45), the Neurological Outcome Scale for TBI46-48 designed to assess focal neurological
deficits associated with TBI, and a TBI history intake interviewmodified from the Brain Injury
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Screening Questionnaire,49 to confirm life history of head injury exposure and identify new head
injuries sustained since last evaluation. Participants then completed the Quality of Life after Brain
Injury50,51 questionnaire capturing current life satisfaction.
The psychiatric evaluation included structured interviews and self-administered questionnaires.
The Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual of Mental Disorders
(Fourth Edition) (CAPS)52 andMontgomery-Asberg Depression Rating Scale53 for depression were
administered as structured interviews before the participant completed the: PCL-M,34 BDI,35 Brief
Symptom Inventory-Anxiety module,54 Insomnia Severity Index,55 and Michigan Alcohol Screening
Test.56 The CAPS was scored using the rules from Blake et al.57
Statistical Analysis
Data analysis was completed June to July 2018. Differences in patient characteristics between the
mild blast TBI and combat-deployed control groups were assessed statistically using Mann-Whitney
and Fisher exact tests as appropriate. Becausemany of the outcomemeasures had highly skewed
distributions, differences in 5-year outcomemeasures were assessed using rank-regression
modeling58 (ie, linear regression on the ranks of themeasures) that adjusted for age, education, sex,
rank, branch of service, and subsequent concussion exposure with the resulting probability values
corrected for multiple comparisons59 within each outcome domain per Benjamini-Hochberg60
(2-sided P values <.05 were considered significant).
Univariate andmultivariate predictive models in 4 domains of 5-year outcomewere
constructed from a predetermined set of measures collected acutely in combat using logistic
regression for global disability (dichotomized GOS-E) and linear regression for neurobehavioral
impairment (NRS-R), PTSD severity (CAPS), and a cumulative measure of Cognitive Performance.
Overall cognitive function for each participant was defined by aggregating the 19 neuropsychological
measures into a single equally weighted rank-based compositemetric.61 This cognitivemean sample
percentile was calculated by converting each score to a within-measure percentile (ranging from 0
to 100) and averaging all such percentile values within each participant. Each percentile was
calculated by dividing each score's rank by the number of scores in the combined samples and
multiplying by 100, after first ensuring that all measures had been transformed as necessary such
that a low score corresponded to a good outcome.
A forward-stepwise selection algorithm (P < .05 to enter, P > .10 to exit) was used to establish a
model for each outcome. Predictive accuracy of the logistic regressionmodels was characterized by
analyzing the receiver operating characteristic (ROC) curve and for the 3 linear regression models it
was characterized by the correlation between the predicted and actual scores. In addition to the
in-sample performance, bootstrap validation was used to provide amore generalizable estimate of
model performance.62 Modeling results are reported following bootstrap validation and indicated
with subscript “BV” to distinguish from initial regression results. Prediction of poor outcomewas also
explored if only a single acute clinical assessment could be used and assessed using ROC curve
analysis, with the diagnostic threshold set at the value where the sum of the sensitivity and
specificity is maximized. Five-year outcome in the global disability domain was considered poor if
GOS-E was 6 or less, in the neurobehavioral domain if NRS-R was 10 or greater, and in the PTSD
domain if CAPS was 65 or above. The ROC curves included both concussive blast and combat-
deployed controls. When looking at prediction of 2 or more domains of poor outcome, those with
poor outcome in 1 domain were excluded from the analysis.
Results
In total, 90 of 100 invited service members completed both 0-to-7 day and 5-year evaluation: 45
concussive blast TBI and 45 combat-deployed controls (Table). Ten service members invited did not
complete follow-up owing to continued deployment and related service obligations. Comparison by
group of those who completed 5-year follow-up vs those who did not identified no significant
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differences in age, sex, branch of service, military rank, or number of deployments for the concussive
blast group, whereas age andmilitary rank slightly differed in the controls who completed follow-up
(eTable 1 in the Supplement). Given the demographic differences between groups, all comparisons of
clinical measures were adjusted for age, education, sex, rank, branch of service, in addition to
subsequent concussion exposures followed by correction for multiple comparisons with final
adjusted and corrected P values reported.
Clinical evaluation at 5-year follow-up of service members with nonmedically evacuated
concussive blast injury identified considerably worse outcomes onmanymeasures compared with
combat-deployed controls (Figure 1) (eTable 2 in the Supplement). A significantly greater number of
patients with concussive blast injury presentedwithmore severe levels of global disability (Figure 1A)
(mean [SD] CTL, 7.4 [0.8]; TBI, 5.8 [1.1]; P < .001) and poor quality of life (Figure 1B) (mean [SD] CTL,
24.1 [4.8]; TBI, 18.9 [4.4]; P = .001). Overall neurobehavioral impairment (Figure 1C) (mean [SD] CTL,
5.6 [5.2]; TBI, 14.8 [6.8]; P < .001) was significantly elevated in patients with concussive blast injury.
The frequency of focal neurological deficits was also significantly elevated in patients with concussive
blast injury with themost common deficit being unilateral or bilateral hearing loss, followed by
olfactory dysfunction and partial sensory loss in a lower extremity (Figure 1D) (mean [SD] CTL, 0.53
[0.76]; TBI, 2.76 [1.76]; P < .001). Posttraumatic headache frequency and impairment was also
significantly worse in nonmedically evacuated patients with concussive blast injury (Figure 1E) (mean
[SD] CTL, 3.1 [6.1]; TBI, 14.4 [16.6]; P = .004) (Figure 1F) (mean [SD] CTL, 49.0 [12.5]; TBI, 59.8 [11.3];
P = .01). Assessment for additional exposures that may have occurred between the time of
enrollment to 5-year follow-up did not identify any additional TBI diagnoses; however, 18 patients
with concussive blast injury and 5 combat-deployed controls reported events that would be
suggestive of additional concussion althoughmedical attention was not sought. Events were
primarily fights or low speedmotor vehicle/motorcycle/bicycle crashes for concussive-blast and
ground level falls for both groups.
In contrast, of the 10 neuropsychological assessments administered, only the 25-foot walk was
significantly different between groups (eTable 4 in the Supplement). Patients with concussive blast
Table. Participant Characteristics at 5-Year Follow-up
Characteristic
Combat Controls
(n = 45)
Concussive Blast TBI
(n = 45) P Valuea
Age, mean (SD), y 34.4 (6.7) 30.6 (5.3) .004
Education, mean (SD), y 16.6 (3.4) 13.6 (1.7) <.001
Sex, No. (%)
Male 33 (73) 44 (98)
.002
Female 12 (27) 1 (2)
Race/ethnicity, No. (%)b
White 35 (78) 32 (71)
.63
Black 3 (7) 2 (4)
Hispanic/Latino 7 (16) 10 (22)
Asian 0 (0) 1 (2)
Branch of service, No. (%)c
US Army 13 (29) 39 (87)
<.001
US Air Force 5 (11) 0 (0)
US Marine Corps 5 (11) 5 (11)
US Navy 22 (49) 1 (2)
Military rank, No. (%)
Enlisted 29 (64) 43 (96)
<.001
Officer 16 (36) 2 (4)
No. of deployments, mean (SD) 1.5 (0.9) 1.8 (1.2) .22
Service separation, No. (%) 16 (36) 27 (60) .03
Abbreviation: TBI, traumatic brain injury.
a Statistical significance byMann-Whitney or Fisher
exact test as appropriate.
b Race/ethnicity computed as white vs other.
c Branch of service computed as Army vs other.
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Figure 1. Five-Year Global Outcome, Quality of Life, and Neurobehavioral Impairment in Nonmedically Evacuated Blast Concussion
and Combat-Deployed Controls (CTL)a
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A, Overall global disability assessed by the GlasgowOutcome Scale Extended (GOS-E, 7
or 8 categorized as good outcome and GOS-E 6 or below categorized as poor outcome).
B, Overall life satisfaction assessed by the Quality of Life After Traumatic Brain Injury
(QOLIBRI; max, 30). C, Overall neurobehavioral symptom severity assessed by the
Neurobehavioral Rating Scale Revised (NRS-R; max, 87). D, Focal neurological deficits
assessed by the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI; max,
58). Headache impairment assessed by E, the Migraine Disability Assessment (MIDAS;
max, 270) and F, the Headache Impact Test (HIT-6; max, 78; min, 36). Each symbol
represents an individual participant, horizontal lines indicate mean (SD) for each graph
with corresponding values reported for each outcome in the legend. Lower values on
panels A and B indicate worse outcome. Higher values on panels C through F indicate
worse outcome. Complete summary statistics includingmeasures of uncertainty are
reported in eTable 2 in the Supplement.
a All P values adjusted.
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injury performed equivalently on all of the other cognitive test measures compared with combat-
deployed controls.
Examination on a variety of psychiatric measures did reveal significant long-term
symptomatology in nonmedically evacuated patients with concussive blast injury related to the blast
exposure compared with combat-deployed controls (Figure 2) (eTable 3 in the Supplement). There
was significant PTSD symptom severity identified by both clinical interview (CAPS) and self-
administered questionnaire (PCL-M) (Figure 2A) ( mean [SD] CTL, 26.8 [21.7]; TBI, 55.0 [29.1];
P = .004) (Figure 2B) (mean [SD] CTL, 27.4 [11.8]; TBI, 44.7 [16.6]; P < .001). Depressive symptoms
were also significantly elevated on the clinical interview (Montgomery-Asberg Depression Rating
Scale) and questionnaire (BDI) but to a lesser extent than PTSD symptoms (Figure 2C) (mean [SD]
CTL, 9.0 [8.5]; TBI, 16.7 [10.6]; P = .05) (Figure 2D) (mean [SD] CTL, 6.1 [7.7]; TBI, 13.4 [9.8]; P = .01).
Self-endorsed anxiety symptoms (Brief Symptom Inventory-AnxietyModule) and sleep impairment
were significantly worse, whereas there was no difference in alcohol misuse between the 2 groups
(Figure 2E) (mean [SD] CTL, 3.0 [3.5]; TBI, 7.2 [5.4]; P = .007) (Figure 2F) (mean [SD] CTL, 7.4 [6.0];
TBI, 12.7 [7.2]; P = .01) (Figure 2G) (mean [SD] CTL, 1.7 [2.6]; TBI, 3.1 [3.6]; P = .49). Importantly, 35
patients (78%) with concussive blast injury and 25 combat-deployed controls (56%) reported
seekingmental health services but only 13 patients (28%) with concussive blast injury and 18
combat-deployed controls (40%) reported sustained symptom resolution.
Owing to the number of nonmedically evacuated patients with concussive blast injury with poor
5-year outcomes, we investigated if any of the acutely collectedmeasures could predict these
outcomes. Four primary outcome domains were examined using univariate and then forward-
stepwise selectionmultivariate modeling for global disability, neurobehavioral impairment, PTSD
symptom severity, and overall cognitive function (Figure 3) (eTables 5-8 in the Supplement).
Figure 2. Five-Year Psychiatric Symptom Severity in Nonmedically Evacuated Blast Concussion and Combat-Deployed Controls (CTL)a
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TBI Indicates traumatic brain injury. A, Posttraumatic stress disorder (PTSD) severity
assessed by the clinician-administered PTSD scale for DSM IV (CAPS; max, 136), and B,
the self-administered PTSD checklist military version (PCL-M; max, 85; Min, 17). C,
Depression severity assessed by theMontgomery-Asberg depression rating scale
(MADRS; max, 60), and D, the self-administered Beck Depression Inventory (BDI; max,
63). E, Anxiety symptom severity assessed by the Brief Symptom Inventory Anxiety
module (BSI-A; max, 24). F, Severity of poor sleep assessed by the Insomnia Severity
Index (ISI; max, 28). G, Alcohol misuse assessed by theMichigan Alcohol Screening Test
(MAST; max, 22). Dotted lines indicate the threshold for moderate to severe
symptomatology for each evaluation. Each symbol represents an individual participant,
horizontal lines indicate mean (SD) for each graph with corresponding values reported
for each outcome in the legend. Higher values on eachmeasure indicate worse outcome.
Complete summary statistics includingmeasures of uncertainty are reported in eTable 3
in the Supplement.
a All P values adjusted.
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Traumatic brain injury diagnosis (odds ratio [OR], 7.86; P = .001) and concussion symptoms (RPCSQ;
OR, 1.06; P = .008) collected acutely in theater best predicted 5-year global disability (AUCBV = 0.79
indicating very strong predictive strength) (Figure 3A) (eTable 5 in the Supplement). Traumatic brain
injury diagnosis (B = 7.01, P < .001), being enlisted (B = 4.06, P = .004), depression symptoms (BDI,
B = 0.25, P = .006), and information processing speed (ANAM-PRT, B = 0.10, P = .02), and visual
spatial memory (ANAM-MTS, B = −0.19, P = .001) collected acutely in theater best predicted 5-year
neurobehavior impairment (RBV = 0.60 indicating strong predictive strength) (Figure 3B) (eTable 6 in
the Supplement). Traumatic brain injury diagnosis (B = 17.59, P = .006) and concussion symptoms
(RPCSQ, B = 0.72, P = .004) collected acutely best predicted 5-year PTSD severity (RBV = 0.36
indicating moderate predictive strength) (Figure 3C) (eTable 7 in the Supplement). Traumatic brain
injury diagnosis (B = 5.35, P = .007), working memory (ANAM-MTP, B = −0.45, P = .001), and
balance performance (BESS, B = −0.27, P = .02) best predicted 5-year cognitive function (RBV = 0.34
indicating moderate prediction strength) (Figure 3D) (eTable 8 in the Supplement).
Given the austere nature of the acute critical care environment in combat, we next asked the
question, if only a single evaluation tool could be used following concussion diagnosis, what measure
would best predict these domains of 5-year outcome. Acute collection of PTSD symptoms (PCL-M)
provided the strongest predictive ability for the 3 domains where patients with concussive blast
injury had worse impairment (global disability, AUC = 0.68; neurobehavioral impairment, R = 0.68;
PTSD symptoms, R = 0.58; eTable 9A-C in the Supplement). Investigation of a PCL-M threshold for
this predictive model identified a score of 27 as the optimal cut point in predicting 1 poor outcome
Figure 3. Acute Predictors of 5-Year Outcome for Global Disability, Neurobehavioral Impairment,
Posttraumatic Stress Disorder (PTSD) Symptom Severity, and Cognitive Performance
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(AUC = 0.74) (Figure 4A) or more than 1 poor outcome (AUC = 0.77) (Figure 4B) indicating fair
predictive strength. Examination of the PCL-M scores in the very same participants for each group
collected acutely in combat and 5 years later revealed an overall average increase of 30% in combat-
deployed controls and 54% in nonmedically evacuated patients with concussive blast injury with
most patients with concussive blast injury noting increased symptom burden (Figure 4C). Percent
change was derived by taking the difference between the 2 scores and dividing by the initial score.
Discussion
At 5-year follow-up, service members with nonmedically evacuated concussive blast injury fared
significantly more poorly than combat-deployed controls onmeasures of global disability,
neurobehavioral impairment, and psychiatric symptom severity whereas cognitive test performance
was similar. Predictors of overall 5-year clinical outcome across 4 different domains primarily
encompassed TBI diagnosis and acute symptoms of mental health and concussion, not acute
cognitive performance, age, sex, number of prior deployments, or number of subsequent
concussions. When considering only a single assessment tool, the PCL-M for PTSD symptoms
collected acutely in theater best predicted domains of outcome in combination with concussion
diagnosis at a cut point of 27 that is lower than the threshold typically used to indicate clinical
significance of 35.34 Both combat-deployed controls and, to a greater extent, nonmedically
evacuated patients with concussive blast injury had a substantial increase in PTSD symptom severity
over the 5-year period suggesting an evolution, not resolution, of mental health burden.
Figure 4. Acute PCL-M Score Threshold for Prediction of 5-YearMultidomain Poor Outcome
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If only a single evaluation tool could be used in combat,
the Posttraumatic Stress Disorder (PTSD) Checklist
Military Version (PCL-M) was found to have the best
predictive ability to inform poor global disability,
neurobehavioral impairment, and PTSD outcome. A
threshold of 27 provided the best cut point regardless
of whether the logistic regression model sought to
identify only A, 1 domain of poor outcome (area under
the curve [AUC] = 0.74) or B, multiple domains
(AUC = 0.77), with both indicating fair predictive
strength. C. Self-administered PTSD Checklist Military
Version was completed at 0 to 7 days postinjury in
combat and at 5-year outcome for direct comparison
over time (PCL-M; max, 85). Line plots indicate change
in score for each concussive blast patient and
combat-deployed control participant. The brown
dashed line indicates the current clinical threshold
whereas the solid brown line indicates the threshold
identified by the current prediction modeling. See
eTable 9 in the Supplement for complete details of
model optimization parameters for this multidomain
outcome prediction includingmeasures of uncertainty.
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These results are comparable to our previous 5-year findings in patients with medically
evacuated concussive blast injury31 suggesting a more universal effect of these concussive blast
exposures irrespective of evacuation status. Like themedically evacuated cohort, this group of
service members with nonmedically evacuated concussion was found to have amuch greater level
of global disability than previously reported in prospective studies of comparable civilian patients
with mild TBI, even those with multisystem trauma.63,64 This has important implications for the
translatability of these combined concussive blast findings because there are far greater numbers of
service members who sustain concussion exposures in combat that are not medically evacuated.
This has been a limitation of our prior work and here we provide prospective, longitudinal evidence
for the progression in this nonmedically evacuated blast concussion population. Furthermore, the
disproportionate number of patients with concussive blast injury with subsequent exposures is in
line with prior work reporting that brain injury is in fact a risk factor for further TBI.65,66
Strengths of this study include the prospective, observational, longitudinal study design,
evaluation in multiple domains of function at both time points, enrollment of a combat-deployed
control group for comparison with the patients with concussive blast injury, concussion diagnosis
made by trained clinicians in combat not based on self-report recollection, collection of medical
history accounting for subsequent exposures that may have occurred between points of evaluation,
and clinical evaluations made by blinded examiners.
Limitations
Limitations of the study include themodest sample size, lack of demographic matching,
heterogeneous treatment centers in which these patients have sought care in the United States, and
unmeasured covariates that may influence these findings such as preinjury characteristics including
military operation specialty, or postinjury behavioral health referrals, use of sick leave, or unmeasured
alcohol use not identified on the alcohol screening test completed as part of the study. In addition,
because of the sample size, it is possible that type II error may have contributed to the
neuropsychological results in which few differences between groups were observed. Furthermore,
the study was designed to explore predictors of long-term outcome without necessarily causal
relation, so the predictors identified should not be assumed to be causally related to the concussion
exposure. It should also be noted that while the predictive models were assessed for model
performance by bootstrap validation, we cannot rule out the possibility of unappreciated overfitting
and therefore replication in an independent cohort should be completed before the models are
considered fully validated.
Conclusions
The results support a more focused and efficient acute screening of mental health in theater
following TBI diagnosis as strong indicators of poor long-term outcome. The PCL-Mwas found to be
the most informative measure in predicting long-term functional outcome following blast-related
mild TBI and can be completed within 1 to 2minutes, supporting its utility in an acute triage
environment. Future studies should examine whether early intervention informed by this acute
assessment may prevent some of the adverse long-term outcomes associated with blast-related
mild TBI.
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